Literature DB >> 34156633

Nisin Induces Cell-Cycle Arrest in Free-Living Amoebae Acanthamoeba castellanii.

Marianna de Carvalho Clímaco1, Yrna Lorena Matos de Oliveira1, Anne Caroline Santos Ramos1, Jucicleide Ramos-de-Souza1, Audrey Rouse Soares Tavares Silva1,2, Sona Jain3, Marilise Brittes Rott4, Ricardo Scher2, Cristiane Bani Correa2, Ana Andrea Teixeira Barbosa5, Silvio Santana Dolabella6.   

Abstract

PURPOSE: Acanthamoeba spp. are free-living amoebas with worldwide distribution and play an important role as disease-causing agents in humans. Drug inability to completely eradicate these parasites along with their toxic effects suggest urgent need for new antimicrobials. Nisin is a natural antimicrobial peptide produced by Lactococcus lactis. Nisin is also the only bacteriocin approved for use in food preservation. In this work, we analyzed the effect of nisin on the growth of Acanthamoeba castellanii trophozoites.
METHODS: A total of 8 × 104 trophozoites were exposed to increasing concentrations of nisin to determine its activity. Changes in cell membrane and cellular cycle of trophozoites were investigated by flow cytometry, and nisin cytotoxicity in mammalian cells was evaluated in L929 cells by MTT method.
RESULTS: After 24 h exposure to increasing nisin concentrations, an IC50 of 4493.2 IU mL-1 was obtained for A. castellanii trophozoites. However, after 72 h a recovery in amoebic growth was observed, and it was no longer possible to determine IC50. Flow cytometry analysis showed that nisin has no effect on the membrane integrity. Treatment with nisin induced cell-cycle arrest during G1 and S phases in A. castellanii trophozoites, which recovered their growth after 72 h.
CONCLUSION: This is one of the first studies showing the effect of internationally approved nisin against A. castellanii trophozoites. Nisin caused cell-cycle arrest in trophozoites, momentarily interfering with the DNA replication process. The data highlight the amoebostatic activity of nisin, and suggest its use as an adjuvant for the treatment of infections caused by Acanthamoeba spp.
© 2021. Witold Stefański Institute of Parasitology, Polish Academy of Sciences.

Entities:  

Keywords:  Acanthamoeba castellanii; Bacteriocins; Free-living amoeba; Mode of action

Mesh:

Substances:

Year:  2021        PMID: 34156633     DOI: 10.1007/s11686-021-00436-x

Source DB:  PubMed          Journal:  Acta Parasitol        ISSN: 1230-2821            Impact factor:   1.440


  30 in total

1.  The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis.

Authors:  Dana Robaei; Nicole Carnt; Darwin C Minassian; John K G Dart
Journal:  Ophthalmology       Date:  2014-03-14       Impact factor: 12.079

Review 2.  Bacteriocins: Recent Trends and Potential Applications.

Authors:  Vandana Bali; Parmjit S Panesar; Manab B Bera; John F Kennedy
Journal:  Crit Rev Food Sci Nutr       Date:  2016       Impact factor: 11.176

Review 3.  Functions and emerging applications of bacteriocins.

Authors:  Michael L Chikindas; Richard Weeks; Djamel Drider; Vladimir A Chistyakov; Leon Mt Dicks
Journal:  Curr Opin Biotechnol       Date:  2017-08-05       Impact factor: 9.740

Review 4.  Update on Acanthamoeba Keratitis: Diagnosis, Treatment, and Outcomes.

Authors:  Nicholas J R Maycock; Rakesh Jayaswal
Journal:  Cornea       Date:  2016-05       Impact factor: 2.651

5.  Acanthamoeba keratitis therapy: time to cure and visual outcome analysis for different antiamoebic therapies in 227 cases.

Authors:  Vincenzo Papa; Paolo Rama; Cherry Radford; Darwin C Minassian; John K G Dart
Journal:  Br J Ophthalmol       Date:  2019-08-10       Impact factor: 4.638

Review 6.  Therapeutic agents and biocides for ocular infections by free-living amoebae of Acanthamoeba genus.

Authors:  Linda Christian Carrijo-Carvalho; Viviane Peracini Sant'ana; Annette Silva Foronda; Denise de Freitas; Fabio Ramos de Souza Carvalho
Journal:  Surv Ophthalmol       Date:  2016-11-09       Impact factor: 6.048

7.  Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis.

Authors:  Natasha L Herz; Alice Y Matoba; Kirk R Wilhelmus
Journal:  Ophthalmology       Date:  2008-05       Impact factor: 12.079

8.  Fatal Granulomatous Amebic Encephalitis in a Heart Transplant Patient: Clinical, Radiographic, and Autopsy Findings.

Authors:  William T Harrison; Bruce Lecky; Christine M Hulette
Journal:  J Neuropathol Exp Neurol       Date:  2018-11-01       Impact factor: 3.685

9.  Occurrence and molecular characterization of free-living amoeba species (Acanthamoeba, Hartmannella, and Saccamoeba limax) in various surface water resources of Iran.

Authors:  Mohammad Reza Mahmoudi; Behnaz Rahmati; Seyed Hosssen Seyedpour; Panagiotis Karanis
Journal:  Parasitol Res       Date:  2015-09-08       Impact factor: 2.289

10.  Are cataract and iris atrophy toxic complications of medical treatment of acanthamoeba keratitis?

Authors:  Niels Ehlers; Jesper Hjortdal
Journal:  Acta Ophthalmol Scand       Date:  2004-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.